BRISTOL-MYERS SQUIBB COMPANY Increase (Decrease) in Income Taxes Payable
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Increase (Decrease) in Income Taxes Payable of -$335.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was -$522.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was $187.00M, a 246.30% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was -$324.00M, a 367.77% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was $887.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in income taxes payable for fiscal 2025 was -$4.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in income taxes payable for fiscal 2024 was -$1.26B.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in income taxes payable for fiscal 2023 was -$603.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in income taxes payable for fiscal 2022 was -$1.42B.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 3 month as first filed | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 6 month as first filed | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 9 month as first filed | Increase (Decrease) in Income Taxes Payable 12 month | Increase (Decrease) in Income Taxes Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$522.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$335.00M 10-Q · filed 2026-07-30 | -$659.00M derived: sum of 3 quarters · filed 2026-07-30 | $228.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $187.00M 10-Q · filed 2026-04-30 | -$137.00M derived: sum of 2 quarters · filed 2026-04-30 | $750.00M derived: sum of 3 quarters · filed 2026-04-30 | $129.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$324.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $563.00M derived: sum of 2 quarters · filed 2026-02-11 | -$58.00M derived: sum of 3 quarters · filed 2026-07-30 | -$4.00M 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | $887.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $266.00M derived: sum of 2 quarters · filed 2026-07-30 | $320.00M 10-Q · filed 2025-10-30 | $441.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$621.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$567.00M 10-Q · filed 2026-07-30 | -$446.00M derived: sum of 3 quarters · filed 2026-07-30 | -$794.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $54.00M 10-Q · filed 2026-04-30 | $175.00M derived: sum of 2 quarters · filed 2026-04-30 | -$173.00M derived: sum of 3 quarters · filed 2026-04-30 | -$2.12B derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $121.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$227.00M derived: sum of 2 quarters · filed 2026-02-11 | -$2.17B derived: sum of 3 quarters · filed 2026-02-11 | -$1.26B 10-K · filed 2026-02-11 | ||||
| 2024-09-30 | -$348.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$2.29B derived: sum of 2 quarters · filed 2025-10-30 | -$1.38B 10-Q · filed 2025-10-30 | -$337.00M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | -$1.94B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$1.03B 10-Q · filed 2025-07-31 | $11.00M derived: sum of 3 quarters · filed 2026-02-11 | -$401.00M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | $910.00M 10-Q · filed 2025-04-24 | $1.95B derived: sum of 2 quarters · filed 2026-02-11 | $1.54B derived: sum of 3 quarters · filed 2026-02-11 | -$577.00M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $1.04B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $632.00M derived: sum of 2 quarters · filed 2026-02-11 | -$1.49B derived: sum of 3 quarters · filed 2026-02-11 | -$603.00M 10-K · filed 2026-02-11 | ||||
| 2023-09-30 | -$412.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$2.53B derived: sum of 2 quarters · filed 2024-10-31 | -$1.65B 10-Q · filed 2024-10-31 | -$2.76B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$2.12B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | -$1.24B 10-Q · filed 2024-07-26 | -$2.35B derived: sum of 3 quarters · filed 2025-02-12 | -$2.29B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $884.00M 10-Q · filed 2024-04-25 | -$229.00M derived: sum of 2 quarters · filed 2025-02-12 | -$169.00M derived: sum of 3 quarters · filed 2025-02-12 | -$1.37B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$1.11B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$1.05B derived: sum of 2 quarters · filed 2025-02-12 | -$2.25B derived: sum of 3 quarters · filed 2025-02-12 | -$1.42B 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $60.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$1.14B derived: sum of 2 quarters · filed 2023-10-26 | -$310.00M 10-Q · filed 2023-10-26 | -$532.00M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-06-30 | -$1.20B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | -$370.00M 10-Q · filed 2023-07-27 | -$592.00M derived: sum of 3 quarters · filed 2024-02-13 | -$638.00M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-03-31 | $831.00M 10-Q · filed 2023-04-27 | $609.00M derived: sum of 2 quarters · filed 2024-02-13 | $563.00M derived: sum of 3 quarters · filed 2024-02-13 | -$459.00M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2021-12-31 | -$222.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$268.00M derived: sum of 2 quarters · filed 2024-02-13 | -$1.29B derived: sum of 3 quarters · filed 2024-02-13 | -$1.06B 10-K · filed 2024-02-13 | ||||
| 2021-09-30 | -$46.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | -$1.07B derived: sum of 2 quarters · filed 2022-10-26 | -$841.00M 10-Q · filed 2022-10-26 | -$1.04B derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-06-30 | -$1.02B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$795.00M 10-Q · filed 2022-07-27 | -$996.00M derived: sum of 3 quarters · filed 2023-02-14 | -$3.29B derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-03-31 | $227.00M 10-Q · filed 2022-04-29 | $26.00M derived: sum of 2 quarters · filed 2023-02-14 | -$2.26B derived: sum of 3 quarters · filed 2023-02-14 | -$2.31B derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2020-12-31 | -$201.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$2.49B derived: sum of 2 quarters · filed 2023-02-14 | -$2.53B derived: sum of 3 quarters · filed 2023-02-14 | -$2.31B 10-K · filed 2023-02-14 | ||||
| 2020-09-30 | -$2.29B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$2.33B derived: sum of 2 quarters · filed 2021-10-27 | -$2.10B 10-Q · filed 2021-10-27 | -$1.19B derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | -$44.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $185.00M 10-Q · filed 2021-07-28 | $1.10B derived: sum of 3 quarters · filed 2022-02-09 | $1.13B derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $229.00M 10-Q · filed 2021-04-29 | $1.14B derived: sum of 2 quarters · filed 2022-02-09 | $1.18B derived: sum of 3 quarters · filed 2022-02-09 | $1.02B derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $911.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $946.00M derived: sum of 2 quarters · filed 2022-02-09 | $787.00M derived: sum of 3 quarters · filed 2022-02-09 | $907.00M 10-K · filed 2022-02-09 | ||||
| 2019-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$124.00M derived: sum of 2 quarters · filed 2020-11-05 | -$4.00M 10-Q · filed 2020-11-05 | $47.00M 10-Q · filed 2019-10-31 | $0.00 derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-06-30 | -$159.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$39.00M 10-Q · filed 2020-08-06 | -$65.00M 10-Q · filed 2019-07-25 | -$35.00M derived: sum of 3 quarters · filed 2021-02-10 | -$52.00M derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-03-31 | $120.00M 10-Q · filed 2020-05-07 | $196.00M 10-Q · filed 2019-04-25 | $124.00M derived: sum of 2 quarters · filed 2021-02-10 | $107.00M derived: sum of 3 quarters · filed 2021-02-10 | $209.00M derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2018-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | -$13.00M derived: sum of 2 quarters · filed 2021-02-10 | $89.00M derived: sum of 3 quarters · filed 2021-02-10 | $203.00M 10-K · filed 2021-02-10 | $162.00M 10-K · filed 2019-02-25 | |||
| 2018-09-30 | -$17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $85.00M derived: sum of 2 quarters · filed 2019-10-31 | $199.00M 10-Q · filed 2019-10-31 | $2.95B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $102.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $216.00M 10-Q · filed 2019-07-25 | $2.97B derived: sum of 3 quarters · filed 2020-02-24 | $2.90B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $114.00M 10-Q · filed 2019-04-25 | $2.87B derived: sum of 2 quarters · filed 2020-02-24 | $2.80B derived: sum of 3 quarters · filed 2020-02-24 | $2.85B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $2.75B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $2.69B derived: sum of 2 quarters · filed 2020-02-24 | $2.74B derived: sum of 3 quarters · filed 2020-02-24 | $3.15B 10-K · filed 2020-02-24 | $2.60B 10-K · filed 2018-02-13 | |||
| 2017-09-30 | -$65.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$14.00M derived: sum of 2 quarters · filed 2018-10-25 | $400.00M 10-Q · filed 2018-10-25 | $130.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $51.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $465.00M 10-Q · filed 2018-07-26 | $195.00M derived: sum of 3 quarters · filed 2019-02-25 | $454.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $414.00M 10-Q · filed 2018-04-26 | $144.00M derived: sum of 2 quarters · filed 2019-02-25 | $403.00M derived: sum of 3 quarters · filed 2019-02-25 | -$91.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | -$270.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$11.00M derived: sum of 2 quarters · filed 2019-02-25 | -$505.00M derived: sum of 3 quarters · filed 2019-02-25 | -$453.00M 10-K · filed 2019-02-25 | -$545.00M 10-K · filed 2017-02-21 | |||
| 2016-09-30 | $259.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$235.00M derived: sum of 2 quarters · filed 2017-10-26 | -$183.00M 10-Q · filed 2017-10-26 | -$262.00M 10-Q · filed 2016-10-27 | -$66.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-30 | -$494.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$442.00M 10-Q · filed 2017-07-27 | -$515.00M 10-Q · filed 2016-07-28 | -$325.00M derived: sum of 3 quarters · filed 2018-02-13 | -$272.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-31 | $52.00M 10-Q · filed 2017-04-27 | $5.00M 10-Q · filed 2016-04-28 | $169.00M derived: sum of 2 quarters · filed 2018-02-13 | $222.00M derived: sum of 3 quarters · filed 2018-02-13 | $165.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-31 | $117.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $170.00M derived: sum of 2 quarters · filed 2018-02-13 | $113.00M derived: sum of 3 quarters · filed 2018-02-13 | $194.00M 10-K · filed 2018-02-13 | $47.00M 10-K · filed 2016-02-12 | |||
| 2015-09-30 | $53.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | -$4.00M derived: sum of 2 quarters · filed 2016-10-27 | $77.00M 10-Q · filed 2016-10-27 | $166.00M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-06-30 | -$57.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $24.00M 10-Q · filed 2016-07-28 | $113.00M derived: sum of 3 quarters · filed 2017-02-21 | $386.00M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-03-31 | $81.00M 10-Q · filed 2016-04-28 | $170.00M derived: sum of 2 quarters · filed 2017-02-21 | $443.00M derived: sum of 3 quarters · filed 2017-02-21 | $467.00M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2014-12-31 | $89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $362.00M derived: sum of 2 quarters · filed 2017-02-21 | $386.00M derived: sum of 3 quarters · filed 2017-02-21 | $171.00M 10-K · filed 2017-02-21 | ||||
| 2014-09-30 | $273.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $297.00M derived: sum of 2 quarters · filed 2015-10-27 | $82.00M 10-Q · filed 2015-10-27 | $80.00M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-30 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | -$191.00M 10-Q · filed 2015-07-23 | -$193.00M derived: sum of 3 quarters · filed 2016-02-12 | -$34.00M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-31 | -$215.00M 10-Q · filed 2015-04-28 | -$217.00M derived: sum of 2 quarters · filed 2016-02-12 | -$58.00M derived: sum of 3 quarters · filed 2016-02-12 | -$166.00M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $157.00M derived: sum of 2 quarters · filed 2016-02-12 | $49.00M derived: sum of 3 quarters · filed 2016-02-12 | $126.00M 10-K · filed 2016-02-12 | ||||
| 2013-09-30 | $159.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $51.00M derived: sum of 2 quarters · filed 2014-10-24 | $128.00M 10-Q · filed 2014-10-24 | -$4.00M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | -$108.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | -$31.00M 10-Q · filed 2014-07-24 | -$163.00M derived: sum of 3 quarters · filed 2015-02-13 | -$156.00M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $77.00M 10-Q · filed 2014-04-29 | -$55.00M derived: sum of 2 quarters · filed 2015-02-13 | -$48.00M derived: sum of 3 quarters · filed 2015-02-13 | $49.00M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | -$132.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$125.00M derived: sum of 2 quarters · filed 2015-02-13 | -$28.00M derived: sum of 3 quarters · filed 2015-02-13 | -$50.00M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $104.00M derived: sum of 2 quarters · filed 2013-10-23 | $82.00M 10-Q · filed 2013-10-23 | -$32.00M derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-06-30 | $97.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $75.00M 10-Q · filed 2013-07-25 | -$39.00M derived: sum of 3 quarters · filed 2014-02-14 | $58.00M derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-03-31 | -$22.00M 10-Q · filed 2013-04-25 | -$136.00M derived: sum of 2 quarters · filed 2014-02-14 | -$39.00M derived: sum of 3 quarters · filed 2014-02-14 | -$86.00M derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2011-12-31 | -$114.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | -$17.00M derived: sum of 2 quarters · filed 2014-02-14 | -$64.00M derived: sum of 3 quarters · filed 2014-02-14 | -$134.00M 10-K · filed 2014-02-14 | ||||
| 2011-09-30 | $97.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $50.00M derived: sum of 2 quarters · filed 2012-10-24 | -$20.00M 10-Q · filed 2012-10-24 | -$69.00M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | -$47.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | -$117.00M 10-Q · filed 2012-07-25 | -$166.00M derived: sum of 3 quarters · filed 2013-02-15 | -$158.00M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | -$70.00M 10-Q · filed 2012-04-26 | -$119.00M derived: sum of 2 quarters · filed 2013-02-15 | -$111.00M derived: sum of 3 quarters · filed 2013-02-15 | -$200.00M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | -$49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$41.00M derived: sum of 2 quarters · filed 2013-02-15 | -$130.00M derived: sum of 3 quarters · filed 2013-02-15 | -$236.00M 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$81.00M derived: sum of 2 quarters · filed 2011-10-27 | -$187.00M 10-Q · filed 2011-10-27 | -$185.00M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-06-30 | -$89.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$195.00M 10-Q · filed 2011-07-28 | -$193.00M derived: sum of 3 quarters · filed 2012-02-17 | -$198.00M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-03-31 | -$106.00M 10-Q · filed 2011-04-28 | -$104.00M derived: sum of 2 quarters · filed 2012-02-17 | -$109.00M derived: sum of 3 quarters · filed 2012-02-17 | -$119.00M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2009-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | -$3.00M derived: sum of 2 quarters · filed 2012-02-17 | -$13.00M derived: sum of 3 quarters · filed 2012-02-17 | $58.00M 10-K · filed 2012-02-17 | ||||
| 2009-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | -$15.00M derived: sum of 2 quarters · filed 2010-10-26 | $56.00M 10-Q · filed 2010-10-26 | |||||
| 2009-06-30 | -$10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-22 | $61.00M 10-Q · filed 2010-07-22 | ||||||
| 2009-03-31 | $71.00M 10-Q · filed 2010-04-29 | |||||||
| 2008-12-31 | $371.00M 10-K · filed 2011-02-18 | |||||||
| 2007-12-31 | -$199.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |